Kannapolis, NC, United States of America

Eric A Button

USPTO Granted Patents = 1 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Eric A Button

Introduction

Eric A Button is a notable inventor based in Kannapolis, NC (US). He has made significant contributions to the field of diabetes management through his innovative patent. His work focuses on improving the estimation of blood glucose excursions in diabetic patients, which is crucial for effective treatment and management of the condition.

Latest Patents

Eric A Button holds a patent for a method of estimation of blood glucose excursions in diabetic patients using the 1,5-anhydroglucitol (1,5-AG) assay. This invention provides a method for measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular. The 1,5-AG assay is particularly useful for identifying diabetic patients who may be at risk for cardiovascular complications that would not be identifiable by A1C levels alone. The ratios of A1C divided by 1,5-AG in each patient serve as superior indicators compared to 1,5-AG levels alone.

Career Highlights

Throughout his career, Eric has worked with prominent companies such as Nippon Kayaku Kabushiki Kaisha and Toyota Tsusho America, Inc. His experience in these organizations has contributed to his expertise in the field of diabetes management and innovation.

Collaborations

Eric A Button has collaborated with esteemed professionals in the field, including John Bernard Buse and Kathleen Dungan. These collaborations have further enhanced his research and development efforts in diabetes care.

Conclusion

Eric A Button's innovative work in diabetes management through his patent demonstrates his commitment to improving patient care. His contributions are vital for advancing the understanding and treatment of diabetes, ultimately benefiting many individuals living with this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…